References
- Bruix J, Gores GJ, Mazzaferro V. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut. 2014;63(5):844–855.
- Yong KJ, Gao C, Lim JS, et al. Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med. 2013;368(24):2266–2276.
- Schneider C, Teufel A, Yevsa T, et al. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer. Gut. 2012;61(12):1733–1743.
- Ji J, Shi J, Budhu A, et al. MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med. 2009;361(15):1437–1447.
- Torre LA, Lee R, Shin MH, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
- Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 2010;7(8):448–458.
- Cooling L. Blood groups in infection and host susceptibility. Clin Microbiol Rev. 2015;28(3):801–870.
- Robinson MG, Tolchin D, Halpern C. Enteric bacterial agents and the ABO blood groups. Am J Hum Genet. 1971;23(2):135–145.
- Prevete N, Liotti F, Amoresano A, et al. New perspectives in cancer: modulation of lipid metabolism and inflammation resolution. Pharmacol Res. 2018;128:80–87.
- Oh S, Kim N, Kwon JW, et al. Effect of helicobacter pylori eradication and ABO genotype on gastric cancer development. Helicobacter. 2016;21(6):596–605.
- Xie J, Qureshi AA, Li Y, et al. ABO blood group and incidence of skin cancer. PLoS One. 2010;5(8):e11972.
- Risch HA, Lu L, Wang J, et al. ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis. Am J Epidemiol. 2013;177(12):1326–1337.
- Li X, Xu H, Ding Z, et al. Association between ABO blood group and HCV-related hepatocellular carcinoma risk in China. Medicine (Baltimore). 2016;95(49):e5587.
- Shim H-J, Lee R, Shin M-H, et al. Association between ABO genotype and risk of hepatocellular carcinoma in Koreans. Asian Pac J Cancer Prev. 2015;16(7):2771–2775.
- Mansour AH, Mohammed MA, Anwar R, et al. ABO blood group and risk of malignancies in Egyptians. Int J Cancer Res. 2014;10(2):81–95.
- Li Q, Yu CH, Jh Y, et al. ABO blood group and the risk of hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B. PLoS One. 2012;7(1):e29928.
- Seham A, Nabeel A, Doaa A, et al. Is there any association between blood groups and hepatocellular carcinoma (HCC)?: a preliminary study. Internet J Hematol. 2007;4(2):1–6.
- Lin XS. The expression and significance of blood group antigens (BGA) A, B, H, Le(a) and Le(b) in hepatocellular carcinoma and chronic hepatitis. Zhonghua Bing Li Xue Za Zhi. 1992;21(1):24–26.
- Iavarone M, Della Corte C, Pelucchi C, et al. Risk of hepatocellular carcinoma in relation to ABO blood type. Dig Liver Dis. 2016;48(1):94–96.
- Marionneau S, Le Moullac-Vaidye B, Le Pendu J. Expression of histo-blood group A antigen increases resistance to apoptosis and facilitates escape from immune control of rat colon carcinoma cells. Glycobiology. 2002;12(12):851–856.
- Zhang BL, He N, Huang YB, et al. ABO blood groups and risk of cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2014;15(11):4643–4650.
- Wang W, Liu L, Wang Z, et al. ABO blood group and esophageal carcinoma risk: from a case-control study in Chinese population to meta-analysis. Cancer Causes Control. 2014;25(10):1369–1377.
- Iodice S, Maisonneuve P, Botteri E, et al. ABO blood group and cancer. Eur J Cancer. 2010;46(18):3345–3350.
- Batool Z, Durrani SH, Tariq S. Association of ABO and Rh blood group types to hepatitis B, hepatitis C, HIV and syphilis infection, A five year’ experience in healthy blood donors in a tertiary care hospital. J Ayub Med Coll Abbottabad. 2017;29(1):90–92.
- Mohammadali F, Pourfathollah A. Association of ABO and Rh blood groups to blood-borne infections among blood donors in Tehran-Iran. Iran J Public Health. 2014;43(7):981–989.
- Poujol-Robert A, Boelle PY, Wendum D, et al. Association between ABO blood group and fibrosis severity in chronic hepatitis C infection. Dig Dis Sci. 2006;51(9):1633–1636.